Study reveals genetic link between mammographic density and breast cancer
Key points
- A University of Melbourne study has revealed that certain breast cancer genetic variants increase mammographic density, confirming the link between mammographic breast density and breast cancer.
- Professor John Hopper of the University's School of Population Health says women vary greatly in their underlying risk of breast cancer.
- "We hope our research on mammographic density will eventually help identify women at higher risk of getting breast cancer.
- The research was conducted in the University's School of Population Health and Department of Pathology along with key national and international collaborators.
A University of Melbourne study has revealed that certain breast cancer genetic variants increase mammographic density, confirming the link between mammographic breast density and breast cancer.
Professor John Hopper of the University's School of Population Health says women vary greatly in their underlying risk of breast cancer. "These findings provide an insight into possible new pathways into the development of breast cancer."
"We hope our research on mammographic density will eventually help identify women at higher risk of getting breast cancer. That is still a way off, but for now women should follow national guidelines for screening," he says.
The research was conducted in the University's School of Population Health and Department of Pathology along with key national and international collaborators. The paper was published today in the prestigious international journal Cancer Research.
"Previous twin studies have suggested there is a genetic link between mammographic density and breast cancer. For the first time, we have been able to identify some of the breast cancer genetic variants involved."

The amount of light areas on a mammogram reveals the mammographic density of a woman's breast. Women who have high mammographic density for their age are at an increased risk of breast cancer.
Using mammograms and blood samples from a study of 830 twin pairs and 600 of their sisters aged between 30 and 80 years recruited via the Australian Twin Registry, researchers investigated 12 genetic variants which are known to be associated with breast cancer.

Dr Jennifer Stone, who led the measurement of mammographic density, says, "We aimed to determine if these genetic variants associated with breast cancer risk also influenced mammographic density. We found at least two variants were linked."
"To date, three other studies had examined this question but have not provided a convincing answer."
"Finding that several genetic variants associated with breast cancer genes are also associated with mammographic density could help explain some of the biological reasons why women of the same age differ so much in mammographic density," Professor Hopper says.
"In doing so, it could also help unravel how these genetic variants are associated with breast cancer risk. This is the beginning of a new research focus on how cancers begin and the role mammographic density plays."

Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsGenetic link to prostate cancer risk in African Americans found
Prostate cancer in African-American men is associated with specific changes in the IL-16 gene, according to researchers at the University of Illinois at Chicago College of Medicine. The study, published online in the…
2 September 2012
NewsNo link seen between bone drugs, colon cancer
Women who use certain bone-building drugs may not have a decreased risk of colon cancer, a new study finds - despite prior evidence suggesting the drugs might offer some protection. The drugs, called bisphosphonates,…
8 June 2012
NewsEvidence strengthens link between NSAIDs and reduced cancer metastasis
A new study reveals key factors that promote the spread of cancer to lymph nodes and provides a mechanism that explains how a common over-the-counter anti-inflammatory medication can reduce the spread of tumor cells…
14 February 2012







